4/A: Tivic Health CEO Amends Stock Option Vesting Schedule

Tivic Health Systems' CEO, Jennifer Ernst, filed an amended Form 4 to correct an administrative error in her stock option vesting schedule.

Summary

• An amendment (Form 4/A) was filed by Jennifer Ernst, CEO and Director of Tivic Health Systems, Inc. (TIVC).
• The purpose of the amendment is to correct an administrative error in the vesting schedule of an employee stock option.
• The original Form 4 was filed on August 8, 2025, and the amendment on August 22, 2025.
• The stock option, granted on August 6, 2025, is for 85,000 shares of common stock with an exercise price of $3.32 and an expiration date of August 5, 2035.
• The corrected vesting schedule states that 25% vests on the first anniversary of the grant date, and the remaining 75% vests in twelve equal quarterly installments thereafter, leading to 100% vesting on the fourth anniversary of the grant date.

Sentiment

Score: 5

Explanation: Neutral. This is an administrative correction of a previously reported transaction and does not indicate any significant positive or negative operational or financial news.

Future Outlook

The filing clarifies the future vesting schedule for 85,000 employee stock options granted to Jennifer Ernst, with 25% vesting on the first anniversary of the grant date and the remaining 75% vesting quarterly over the subsequent three years, leading to full vesting by August 6, 2029.

Management Comments

• "This Amendment No. 1 ('Form 4/A') to the Form 4 filed by the reporting person on August 8, 2025 (the 'Original Form 4') is being filed to correct an administrative error, resulting in the incorrect vesting schedule for the stock option being included in the Original Form 4."
• "As reflected in this Form 4/A, the stock option vests as follows: (i) 25% upon the first anniversary of the grant date, and (ii) the remaining 75% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."

Industry Context

This filing is an individual executive's ownership disclosure and does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Provides clarity on the CEO's equity compensation terms.
• Employees: Standardizes the CEO's equity compensation terms, aligning with typical vesting schedules.

Next Steps

• The stock option will vest according to the corrected schedule: 25% on the first anniversary of the grant date (August 6, 2026), and the remaining 75% in twelve equal quarterly installments thereafter, with full vesting by the fourth anniversary (August 6, 2029).

Key Dates

Recommendation

This filing is an administrative correction of a stock option vesting schedule for the CEO and does not provide new information that would warrant a change in investment recommendation. It clarifies existing compensation terms without impacting the company's operational or financial outlook.

Keywords

Tivic Health Systems, TIVC, Jennifer Ernst, Form 4/A, SEC filing, stock option, vesting schedule, beneficial ownership, CEO, director